Global Rna Polymerases Market Size & Outlook, 2023-2030
Global rna polymerases market, 2018-2030 (US$M)
Related Markets
Global rna polymerases market highlights
- The global rna polymerases market generated a revenue of USD 315.1 million in 2023 and is expected to reach USD 752.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 13.2% by 2030.
- In terms of segment, mrna production accounted for a revenue of USD 238.8 million in 2023.
- MRNA Production is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 315.1 million |
| Market revenue in 2030 | USD 752.5 million |
| Growth rate | 13.2% (CAGR from 2023 to 2030) |
| Largest segment | Mrna production |
| Fastest growing segment | MRNA Production |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MRNA Production, Other Applications |
Other key industry trends
- In terms of revenue, the North America accounted for 38.2% of the global rna polymerases market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 4.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
RNA Polymerases Market Scope
RNA Polymerases Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ABclonal | View profile | 501-1000 | Wuhan, Hubei, China, Asia | https://abclonal.com/ |
| MBL International Corporation | View profile | 101-250 | Woburn, Massachusetts, United States, North America | https://www.mblintl.com/ |
| ArcticZymes Technologies | View profile | 11-50 | Tromsø, Troms, Norway, Europe | https://arcticzymes.com/ |
| Calzyme | View profile | 11-50 | San Luis Obispo, California, United States, North America | https://www.calzyme.com |
| Biovision | View profile | 51-100 | Milpitas, California, United States, North America | https://www.biovision.com |
| BPS Bioscience Inc. | View profile | 51-100 | San Diego, California, United States, North America | http://bpsbioscience.com |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| Abnova | View profile | 251-500 | Taipei, T'ai-pei, Taiwan, Asia | http://www.abnova.com/ |
| Worthington Enterprises Inc | View profile | 8200 | 200 Old Wilson Bridge Road, Columbus, OH, United States, 43085 | https://www.worthingtonindustries.com |
| MyBiosource | View profile | 11-50 | San Diego, California, United States, North America | https://www.mybiosource.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Sino Biological | View profile | 251-500 | Beijing, Beijing, China, Asia | http://www.sinobiological.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global rna polymerases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rna polymerases market will help companies and investors design strategic landscapes.
Mrna production was the largest segment with a revenue share of 75.79% in 2023. Horizon Databook has segmented the Global rna polymerases market based on mrna production, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
- Global RNA Polymerases Application Outlook (Revenue, USD Million, 2018-2030)
- Oligonucleotide synthesis
- Other Applications
- Biopharmaceutical Processing
- mRNA Production
Reasons to subscribe to Global rna polymerases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global rna polymerases market databook
-
Our clientele includes a mix of rna polymerases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global rna polymerases market, including forecasts for subscribers. This global databook contains high-level insights into Global rna polymerases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global rna polymerases market size, by regions, 2018-2030 (US$M)
Top 10 countries: Rna polymerases market size, 2023 (US$M)
Global rna polymerases market share, by application, 2023 & 2030 (%, US$M)
Rna polymerases market: Opportunity assessment by country
Global rna polymerases market, by region, 2023 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
